- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03845673
Fiber Regimens for Constipation Symptoms (constipation)
February 14, 2019 updated by: University of Texas Southwestern Medical Center
Randomized Trial Comparing Two Fiber Regimens for the Reduction of Symptoms of Constipation
The objective of the current study is to compare the effects of bowel recipe with psyllium on symptoms associated with constipation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients presenting to the urogynecology clinics at Parkland Health and Hospital System and UT Southwestern Medical Center at Dallas from July 2003 to July 2005 were screened for symptoms of constipation.
Subjects were randomized to a 6-week course of either psyllium (Konsyl, Konsyl Pharmaceuticals, Easton, MD) or a special bowel recipe.
The bowel recipe was a modification of that used by Behm and consisted of 1 cup of unprocessed wheat bran, 1 cup of applesauce, and 1/4 cup of prune juice.
A validated constipation scoring questionnaire12 was administered to participants at the beginning and at the end of the six-week study period.
During the six-week trial patients also kept a bowel diary recording characteristics of each bowel movement.
Study Type
Interventional
Enrollment (Actual)
53
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Dallas, Texas, United States, 75390
- University of Texas Southwestern Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 78 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- fluent and literate in either English or Spanish.
- responds affirmatively to at least two symptoms according to Rome II criteria for functional constipation, for at least 12 weeks
Exclusion Criteria:
- pregnant or less than six weeks postpartum
- six weeks post abdominal surgery,
- colostomy
- history of bowel obstruction, inflammatory bowel disease, diagnosis of slow colonic transit time, spinal cord injury, neurogenic disease, myopathic disorders, or cognitive impairment, history of an allergic reaction to psyllium or any of the ingredients contained in the bowel recipe, such as wheat bran, prunes, or apples.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Psyllium
This group of patients was given psyllium for 6 weeks
|
Psyllium fiber (Konsyl; Konsyl Pharmaceuticals, Easton, Md)
|
Experimental: Bowel recipe
This group was administered a specialized bowel recipe for 6 weeks
|
consisted of 1 cup of unprocessed wheat bran, 1 cup of applesauce, and 1/4 cup of prune juice.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Constipation questionnaire scores
Time Frame: 6 weeks
|
A validated constipation scoring questionnaire was administered to participants at the beginning and at the end of the 6-week study period.
Previous studies have shown that dietary modifications can result in significant improvement in constipa- tion scores and symptom relief as early as 2 to 6 weeks.
The questionnaire consisted of 8 variables: (i) frequency of bowel movements, (ii) painful evacuation, (iii) incomplete evacuation, (iv) abdominal pain, (v) length of time per attempt, (vi) assis- tance with defecation, (vii) unsuccessful attempts at evacuation per 24 hours, and (viii) duration of constipation.
Each variable was scored on a range of 0 to 4 (except for ''assistance for defecation,'' which was scored from 0 to 2), and a cumulative score was determined.
A global score of 0 is generally considered normal, and a maximum score of 30 indicates severe con- stipation.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
frequency of bowel movements
Time Frame: 6 weeks
|
number of bowel movements per week
|
6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Clifford Y Wai, MD, University of Texas Southwestern Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2003
Primary Completion (Actual)
July 1, 2005
Study Completion (Actual)
July 1, 2005
Study Registration Dates
First Submitted
August 2, 2011
First Submitted That Met QC Criteria
February 14, 2019
First Posted (Actual)
February 19, 2019
Study Record Updates
Last Update Posted (Actual)
February 19, 2019
Last Update Submitted That Met QC Criteria
February 14, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 0703-457
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Constipation
-
usMIMA S.L.CompletedConstipation | Constipation Chronic Idiopathic | Constipation; NeurogenicSpain, United Kingdom
-
AbbVieIronwood Pharmaceuticals, Inc.RecruitingFunctional Constipation (FC) | Chronic Idiopathic Constipation (CIC)United States, United Kingdom, Bulgaria, Netherlands
-
usMIMA S.L.University of York; County Durham and Darlington NHS Foundation TrustNot yet recruitingConstipation | Constipation-predominant Irritable Bowel Syndrome | Constipation - Functional | Constipation Chronic Idiopathic | Constipation; Neurogenic
-
Institute of Medical Sciences and SUM HospitalNot yet recruitingFunctional Constipation | Constipation - Functional | Constipation Chronic Idiopathic | Fecal Impaction | Pediatric Functional ConstipationIndia
-
SK Life Science, Inc.CompletedChronic Constipation | Functional ConstipationUnited States
-
Cairo UniversityUnknownChronic Idiopathic Constipation | Functional ConstipationEgypt
-
ProgenaBiomeRecruitingConstipation | Constipation - Functional | Constipation Chronic Idiopathic | Constipation (Excl Faecal Impaction)United States
-
Pamukkale UniversityRecruiting
-
Shanghai University of Traditional Chinese MedicineLonghua Hospital; Shanghai Municipal Hospital of Traditional Chinese MedicineRecruiting
-
Universidade Nova de LisboaCINTESIS - Center for Health Technology and Services ResearchRecruiting
Clinical Trials on Psyllium
-
Unity Health TorontoUnknownHypercholesterolemia | Cardiovascular Risk Factor
-
University of UtahCompletedKidney DiseaseUnited States
-
Procter and GambleCompleted
-
Hungkuang UniversityNot yet recruitingSchizophrenia | Constipation | PsylliumTaiwan
-
Nutrabiotix, LLCRush University Medical CenterTerminatedConstipation-predominant IBS (IBS-C)United States
-
Francesco GabrielliCompletedConstipation | IncontinenceItaly
-
Procter and GambleDuke UniversityCompletedImpaired Fasting GlucoseUnited States
-
University of NottinghamIronwood Pharmaceuticals, Inc.Completed
-
Procter and GambleCompleted
-
US Department of Veterans AffairsCompletedFecal IncontinenceUnited States